AscendiantLogo Better

Ascendiant Capital Markets

Equity Research

Research Reports

View current research reports or reports on companies.

Equity Research

Ascendiant’s Equity Research team provides in-depth research, analysis, and reporting to the investment community.

Ascendiant’s industry focus includes companies in the following sectors: healthcare (biotech, life sciences, medical device), technology, energy, consumer, media and entertainment, and internet.

Ascendiant’s analysts have been awarded top ranking by Starmine and have received multiple StarMine, Wall Street Journal, Forbes, and Institutional Investor analyst awards.

Our analysts have appeared on major media broadcasts such as CNBC, Bloomberg TV, and Fox Business News, and have been quoted in numerous publications such as the Wall Street Journal, the New York Times, and the Los Angeles Times.

Ascendiant’s equity research is distributed to the financial industry’s primary electronic services, portals, and terminals including Bloomberg, Thomson Reuters, S&P Capital IQ, and FactSet, and to Ascendiant’s proprietary investor database.

Contact Us
Our Latest Research Reports
NYSE American: AIM NYSE American: AIM NYSE American: AIM NYSE American: AIM NYSE American: AIM
NYSE American: AIM NYSE American: AIM NYSE American: AIM NYSE American: AIM NYSE American: AIM

AIM Q1 2022

Ascendiant Research Report

NYSE American: AIM NYSE American: AIM NYSE American: AIM NYSE American: AIM NYSE American: AIM
NYSE American: AIM NYSE American: AIM NYSE American: AIM NYSE American: AIM NYSE American: AIM

AIM Q4 2021

Ascendiant Research Report

Nasdaq: ALZN Nasdaq: ALZN Nasdaq: ALZN Nasdaq: ALZN Nasdaq: ALZN
Nasdaq: ALZN Nasdaq: ALZN Nasdaq: ALZN Nasdaq: ALZN Nasdaq: ALZN

ALZN Q3 FY22

Ascendiant Research Report

Nasdaq: AMTX Nasdaq: AMTX Nasdaq: AMTX Nasdaq: AMTX Nasdaq: AMTX
Nasdaq: AMTX Nasdaq: AMTX Nasdaq: AMTX Nasdaq: AMTX Nasdaq: AMTX

AMTX Q4 2021

Ascendiant Research Report

Nasdaq: AMTX Nasdaq: AMTX Nasdaq: AMTX Nasdaq: AMTX Nasdaq: AMTX
Nasdaq: AMTX Nasdaq: AMTX Nasdaq: AMTX Nasdaq: AMTX Nasdaq: AMTX

AMTX Q1 2022

Ascendiant Research Report

Nasdaq: ATOS Nasdaq: ATOS Nasdaq: ATOS Nasdaq: ATOS Nasdaq: ATOS
Nasdaq: ATOS Nasdaq: ATOS Nasdaq: ATOS Nasdaq: ATOS Nasdaq: ATOS

ATOS Q1 2022

Ascendiant Research Report

Nasdaq: ATOS Nasdaq: ATOS Nasdaq: ATOS Nasdaq: ATOS Nasdaq: ATOS
Nasdaq: ATOS Nasdaq: ATOS Nasdaq: ATOS Nasdaq: ATOS Nasdaq: ATOS

ATOS Q4 2021

Ascendiant Research Report

Nasdaq: ATVI Nasdaq: ATVI Nasdaq: ATVI Nasdaq: ATVI Nasdaq: ATVI
Nasdaq: ATVI Nasdaq: ATVI Nasdaq: ATVI Nasdaq: ATVI Nasdaq: ATVI

ATVI Q4 2021

Ascendiant Research Report

Nasdaq: ATVI Nasdaq: ATVI Nasdaq: ATVI Nasdaq: ATVI Nasdaq: ATVI
Nasdaq: ATVI Nasdaq: ATVI Nasdaq: ATVI Nasdaq: ATVI Nasdaq: ATVI

ATVI Q1 2022

Ascendiant Research Report

Nasdaq: AUTO Nasdaq: AUTO Nasdaq: AUTO Nasdaq: AUTO Nasdaq: AUTO
Nasdaq: AUTO Nasdaq: AUTO Nasdaq: AUTO Nasdaq: AUTO Nasdaq: AUTO

AUTO Q1 2022

Ascendiant Research Report

Nasdaq: AUTO Nasdaq: AUTO Nasdaq: AUTO Nasdaq: AUTO Nasdaq: AUTO
Nasdaq: AUTO Nasdaq: AUTO Nasdaq: AUTO Nasdaq: AUTO Nasdaq: AUTO

AUTO Q4 2021

Ascendiant Research Report

Nasdaq: BIOL Nasdaq: BIOL Nasdaq: BIOL Nasdaq: BIOL Nasdaq: BIOL
Nasdaq: BIOL Nasdaq: BIOL Nasdaq: BIOL Nasdaq: BIOL Nasdaq: BIOL

BIOL Q4 2021

Ascendiant Research Report

Nasdaq: BIOL Nasdaq: BIOL Nasdaq: BIOL Nasdaq: BIOL Nasdaq: BIOL
Nasdaq: BIOL Nasdaq: BIOL Nasdaq: BIOL Nasdaq: BIOL Nasdaq: BIOL

BIOL Q1 2022

Ascendiant Research Report

Get To Know Us

Meet the team that makes everything happen. Putting our clients first, and making sure they are successful, is what drives us each and every day. 

Meet The Team
Bradley Wilhite

Bradley J. Wilhite

Co-Founder & Managing Partner

Leadership, Investment Banking

ASCENDiant Mark

Mark A. Bergendahl

Co-Founder & Managing Partner

Leadership
Our Values

Our Values

01/08

Relationships

We’re in the money business, but we’re really in the people business. Investing in long-term relationships with clients is a fundamental principle of our business strategy, and one of the most rewarding and enjoyable aspects of what we do.

Our Values

02/08

Trust

Trust, along with excellent communication, is essential in any relationship. We value honesty, integrity, transparency, and reliability, and pledge to always do our best to earn your trust.

Our Values

03/08

Highest Standards

We’re not here to sell you, we’re here to serve you. That means doing what is best for your company and your shareholders – based on your needs and objectives, not ours. We’ve run businesses, too, and now we run an investment bank – that will always put you first.

Our Values

04/08

Serve Clients

Our goal is not to be the biggest bank, it’s to be the best – for the clients we serve. Your best financial partner, your best advisor, your best strategist, your best resource, your best sounding board. The best an investment bank has to offer.

Our Values

05/08

Success

Here’s our simple business philosophy and formula for success – maximize relationships, not fees. Success for us is a client achieving its goals and realizing its potential. When our capital is structured in a way that truly meets your needs – and allows you to hire more employees, open a new building, expand R&D, sell more product, or secure a strategic acquisition, that’s our measure of success.

Our Values

06/08

Experience

Most investors and bankers you meet have never run a business, and even fewer have managed a public company. We have unique perspective and insight from your side of the desk because we’ve been there. We appreciate what you do – tackling challenges and pursuing opportunities – and want to do our best to support you. Let our experience and expertise help you make the best decisions for your company.

Our Values

07/08

Freedom

A public company needs support from a lot of sources to achieve success. That means multiple investors, analysts, shareholders, and yes, investment banks. In short, you need a lot of investment bank friends, not just one. When an investment bank requires exclusivity or a right of first refusal following a capital raise, they are leveraging the relationship and limiting your company’s options. When you work with us, you have freedom, and that’s best for your business.

Our Values

08/08

Respect

Some investment banks are run like a money printing machine – deal after deal, and fees on top of fees. You get calls, e-mails, and texts all hours of the day, night, and weekends, pushing you to accept an offer. That’s not our style, and we’re respectful of your time and your life away from the office. We’ll listen to your needs and objectives, present ideas and solutions, and let you make the call.

Ascendiant News

July 25, 2022
Ascendiant Initiates Research Coverage on Intrusion, Inc. (Nasdaq: INTZ)
July 18, 2022
Ascendiant Initiates Research Coverage on Guardion Health Sciences, Inc. (Nasdaq: GHSI)
July 6, 2022
Ascendiant Serves as Sole M&A Advisor on SINTX Technologies, Inc.’s (Nasdaq: SINT) Acquisition of Technology Assessment & Transfer, Inc. (TA&T)
June 27, 2022
Ascendiant Initiates Research Coverage on Blackboxstocks Inc. (Nasdaq: BLBX)
June 23, 2022
Ascendiant Capital Markets LLC serves as Sole M&A Advisor on Sale of Pinnacle Precision to The Partner Companies
June 15, 2022
Ascendiant Capital Markets LLC serves as Sole Sales Agent on $46,400,000 At-the-Market (ATM) Offering for BitNile Holdings, Inc.’s Series D Preferred Stock (NYSE American: NILE PRD)
May 31, 2022
Ascendiant Serves as Sole Placement Agent on $6,015,000 Private Placement for Nemaura Medical, Inc. (Nasdaq: NMRD), Increases Total Amount to $36,045,000 over Three Transactions
April 7, 2022
Ascendiant Serves as Financial Advisor on $50,000,000 Registered Direct for PAVmed Inc. (Nasdaq: PAVM)
April 4, 2022
Ascendiant Serves as Sole Sales Agent on $9,360,000 At-The-Market (ATM) Offering for ENDRA Life Sciences, Inc. (Nasdaq: NDRA)
March 10, 2022
Ascendiant Serves as Sole Placement Agent on $10,700,000 Private Placement for Intrusion, Inc. (Nasdaq: INTZ)
February 28, 2022
Ascendiant Serves as Sole Sales Agent on $200,000,000 At-the-Market (ATM) Offering for BitNile Holdings, Inc. (NYSE American: NILE)
January 24, 2022
Ascendiant Initiates Research Coverage on SurgePays, Inc. (Nasdaq: SURG)